A Multicenter, Open-label Extension Trial to Assess the Long-term Use of Lacosamide Monotherapy and Safety of Lacosamide Monotherapy and Adjunctive Therapy in Subjects With Partial-onset Seizures.
Phase of Trial: Phase III
Latest Information Update: 30 Aug 2017
At a glance
- Drugs Lacosamide (Primary)
- Indications Partial epilepsies
- Focus Therapeutic Use
- Sponsors UCB
- 21 Apr 2016 Post-hoc analysis of responder and seizure freedom rates (n=322) were presented at the 68th Annual Meeting of the American Academy of Neurology.
- 11 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 20 Oct 2014 Planned End Date changed from 1 Jan 2015 to 1 Dec 2014 as reported by ClinicalTrials.gov